A retrospective study conducted at Memorial Sloan-Kettering Cancer Center evaluated local therapy (i.e., radiation therapy, surgical resection, or radiofrequency ablation) for patients with oligoprogressive EGFR-mutant NSCLC on TKI therapy. Here, EGFR is linked to non-small cell lung carcinoma.